Last reviewed · How we verify
Human African trypanosomiasis (HAT) due to Trypanosoma brucei gambiense
Approved treatments
- Fexinidazole · Sanofi
Fexinidazole works by releasing free radicals that damage the DNA of Trypanosoma brucei gambiense, ultimately killing the parasite.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Human African trypanosomiasis (HAT) due to Trypanosoma brucei gambiense patent landscape — cliff calendar, originator estates, attackable patents
- Human African trypanosomiasis (HAT) due to Trypanosoma brucei gambiense treatment landscape brief
- Human African trypanosomiasis (HAT) due to Trypanosoma brucei gambiense treatment updates RSS
Frequently asked questions about Human African trypanosomiasis (HAT) due to Trypanosoma brucei gambiense
What drugs treat Human African trypanosomiasis (HAT) due to Trypanosoma brucei gambiense?
Tracked treatments include Fexinidazole.
What is the treatment for Human African trypanosomiasis (HAT) due to Trypanosoma brucei gambiense?
Standard treatment for Human African trypanosomiasis (HAT) due to Trypanosoma brucei gambiense includes Fexinidazole. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Human African trypanosomiasis (HAT) due to Trypanosoma brucei gambiense patent cliff · Human African trypanosomiasis (HAT) due to Trypanosoma brucei gambiense CI report
- Treatment: Fexinidazole · Sanofi
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing